Go Pro
NASDAQ:BHST

BioHarvest Sciences Q2 2026 Earnings Report

BioHarvest Sciences logo
$2.86 +0.10 (+3.43%)
As of 11:09 AM Eastern
This is a fair market value price provided by Massive. Learn more.

BioHarvest Sciences EPS Results

Actual EPS
N/A
Consensus EPS
-$0.13
Beat/Miss
N/A
One Year Ago EPS
N/A

BioHarvest Sciences Revenue Results

Actual Revenue
N/A
Expected Revenue
$9.45 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

BioHarvest Sciences Announcement Details

Quarter
Q2 2026
Time
Before Market Opens
Conference Call Date
Monday, August 10, 2026
Conference Call Time
8:00AM ET

Conference Call Resources

BioHarvest Sciences Earnings Headlines

Trump’s secret China deal
Trump just returned from Beijing with the most powerful business delegation in American history - Elon Musk, Jensen Huang, Tim Cook, and the CEOs of BlackRock, Goldman Sachs, and CitiBank. The media covered the handshakes. But what was really being negotiated behind closed doors? Porter Stansberry has connected the Beijing trip to a landmark pact signed by 13 nations in Washington - a pact designed to cut China out of a $3 trillion investment wave tied to the most critical resource of the 21st century. His new documentary exposes the five assets at the center of it all.tc pixel
BioHarvest (BHST) Q1 2026 Earnings Transcript
See More BioHarvest Sciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like BioHarvest Sciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioHarvest Sciences and other key companies, straight to your email.

About BioHarvest Sciences

BioHarvest Sciences (NASDAQ:BHST) is a biotechnology company that specializes in the development and commercialization of plant-based active ingredients through proprietary cell-culture technology. By growing undifferentiated plant cells in controlled bioreactor environments, the company aims to produce full-spectrum phytonutrients and botanical compounds that are difficult to obtain through traditional farming methods. This approach is designed to deliver consistent, high-purity extracts with reduced environmental impact and supply-chain variability.

The company’s product portfolio focuses on applications across the cosmeceutical, nutraceutical and health-and-wellness markets. Utilizing its “living plant cell” methodology, BioHarvest Sciences creates concentrates rich in natural antioxidants, peptides and other bioactive molecules. These ingredients are formulated for skin-care serums, dietary supplements and functional beverages, targeting consumers and manufacturers seeking clean-label and scientifically backed botanical solutions.

BioHarvest Sciences has pursued collaborative partnerships with research institutions and commercial enterprises to advance its cell-culture platform and expand market reach. While its technology development is headquartered in North America, the company’s ingredients have attracted interest from cosmetics and food firms in Europe and Asia. As it continues to scale production and refine its bioreactor processes, BioHarvest Sciences positions itself at the intersection of cellular agriculture and plant-derived therapeutics.

View BioHarvest Sciences Profile